 | CAS No. 1207853-23-3, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No. 1227917-63-6, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No. 1207947-49-6, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No.151266-23-8, Futibatinib Intermediate | Futibatinib | 11/05/2039 (Futibatinib) | View detail » | 2017 |
 | CAS No. 910463-68-2, Semaglutide API | Semaglutide | 2/17/2041 (Semaglutide) | View detail » | 2022 |
 | CAS No.171290-52-1, Futibatinib Intermediate | Futibatinib | 11/05/2039 (Futibatinib) | View detail » | 2023 |
 | CAS No.109431-87-0, Futibatinib Intermediate | Futibatinib | 11/05/2039 (Futibatinib) | View detail » | 2020 |
 | CAS No. 6228-73-5, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | |
 | CAS No. 1352925-63-3, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2023 |
 | CAS No. 372118-00-8, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2022 |
 | CAS No. 1609393-89-6, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2023 |
 | CAS No. 679406-03-2, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | |
 | CAS No. 1609394-10-6, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2023 |
 | CAS No. 7436-22-8, Deuterium source | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2018 |
